Join
Live feed
·
PRReleasevia Quantisnow
Biogen Inc. logo
Stoke Therapeutics Inc. logo

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

ByQuantisnow·Wall Street's wire, on your screen.
BIIB· Biogen Inc.STOK· Stoke Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIIB (Biogen Inc.), STOK (Stoke Therapeutics Inc.) and more on Quantisnow.